The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000215.4(JAK3):c.1915-1G>A

CA404768497

2048620 (ClinVar)

Gene: JAK3
Condition: T-B+ severe combined immunodeficiency due to JAK3 deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 60dd60ca-5596-48cc-81d5-5dad6eee4047

HGVS expressions

NM_000215.4:c.1915-1G>A
NM_000215.4(JAK3):c.1915-1G>A
NC_000019.10:g.17835216C>T
CM000681.2:g.17835216C>T
NC_000019.9:g.17946025C>T
CM000681.1:g.17946025C>T
NC_000019.8:g.17807025C>T
NG_007273.1:g.17776G>A
ENST00000458235.7:c.1915-1G>A
ENST00000458235.5:c.1915-1G>A
ENST00000527031.5:n.2278+1511G>A
ENST00000527670.5:c.1915-1G>A
ENST00000534444.1:c.1915-1G>A
NM_000215.3:c.1915-1G>A

Uncertain Significance

Met criteria codes 1
PM2_Supporting
Not Met criteria codes 1
PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for JAK3 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The variant NM_000215.4(JAK3):c.1915-1G>A is predicted to disrupt an acceptor splice site in intron 14; however, this variant falls into a NAGNAG sequence, which may indicate a frame restoring splice site (PVS1 not met). The variant has an allele frequency that is too low to calculate a popmax allele frequency accurately; there is a single heterozygous case (1/112366 alleles or MAF of 0.000008899 in the European non-Finnish population), and no homozygous cases were reported in gnomAD v2.1.1. This is below the SCID VCEP threshold of <0.000115 (PM2_supporting). To our knowledge, the variant has not been reported in the literature in any individuals with JAK3 deficiency. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for autosomal recessive T-B+ severe combined immunodeficiency due to JAK3 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PM2_supporting. (SCID VCEP Specification Version 1).
Met criteria codes
PM2_Supporting
The variant has an allele frequency that is too low to calculate a popmax allele frequency and thus meets PM2_supporting. There is a single heterozygous case (1/112366 alleles or MAF of 0.000008899 in the European non-Finnish population) and no homozygous cases were reported in gnomAD v2.1.1. This is below the SCID VCEP threshold of <0.000115 (PM2_supporting).
Not Met criteria codes
PVS1
The variant NM_000215.4(JAK3):c.1915-1G>A is predicted to disrupt an acceptor splice site in intron 14, however this variant falls into a NAGNAG sequence, which may indicate a frame restoring splice site.
Approved on: 2024-01-17
Published on: 2024-01-17
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.